Biogen
(NASDAQ:BIIB)
$202.19
9.01[4.66%]
Last update: 12:22PM Get Real Time Here
Why is it moving?
Biogen shares are trading higher following a Q1 EPS beat.
Q1 2024 earnings were released today before the market open
Today's conference call ended over 8 hours ago Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
50%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
40
0100

Biogen Stock (NASDAQ:BIIB), Quotes and News Summary

Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.

Open$198.970
Close-
Volume / Avg.1.576M / 1.189M
Day Range198.970 - 205.750
52 Wk Range189.440 - 334.580
Market Cap$29.390B
P/E Ratio24.238
Dividend Yield-
ExchangeNASDAQ
RSI
47
Short Interest
2.76%
Days to Cover2.85

Recent News

Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings
Biogen reports Q1 results: adjusted EPS $3.67 (beat consensus), sales $2.29 billion (missed consensus). Leqembi launch uptake triples, Zurzuvae's early trends encouraging.
Vandana Singh
Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally
Nasdaq and S&P 500 futures signaled a higher open on Wednesday, thanks to upbeat guidance from EV giant Tesla, Inc. (NASDAQ:TSLA) and semiconductor m
Shanthi Rexaline
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.
Shanthi Rexaline
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
4
Dec 23
1
2
Jan
11
2
Feb
2
Mar
2
5
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Biogen Inc
Sector
Health Care
Industry
Biotechnology
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex a...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BIIB
LEGN

FAQ

Q

How do I buy Biogen (BIIB) stock?

A

You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Biogen's (BIIB) competitors?

A

Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

Q

What is the target price for Biogen (BIIB) stock?

A

The latest price target for Biogen (NASDAQ: BIIB) was reported by Needham on Wednesday, April 24, 2024. The analyst firm set a price target for 294.00 expecting BIIB to rise to within 12 months (a possible 45.41% upside). 86 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biogen (BIIB)?

A

The stock price for Biogen (NASDAQ: BIIB) is $202.19 last updated Today at April 24, 2024 at 12:22 PM EDT.

Q

Does Biogen (BIIB) pay a dividend?

A

There are no upcoming dividends for Biogen.

Q

When is Biogen (NASDAQ:BIIB) reporting earnings?

A

Biogen’s Q2 earnings are confirmed for Tuesday, July 23, 2024.

Q

Is Biogen (BIIB) going to split?

A

There is no upcoming split for Biogen.

Q

What sector and industry does Biogen (BIIB) operate in?

A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch